Monthly HIV pill passes heart safety check in early trial
NCT ID NCT07063238
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 34 times
Summary
This study tested whether a higher-than-normal dose of MK-8527, a once-monthly pill to prevent HIV, affects heart rhythm. 42 healthy adults took the study drug, a placebo, or an active control. The main goal was to measure changes in the QT interval, a key heart rhythm marker. The study is complete and results will help decide if this monthly prevention option is safe for the heart.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hassman Research Institute Marlton Site ( Site 0001)
Marlton, New Jersey, 08053, United States
Conditions
Explore the condition pages connected to this study.